Shabbir Moochhala
Overview
Explore the profile of Shabbir Moochhala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cellini B, Baum M, Frishberg Y, Groothoff J, Harris P, Hulton S, et al.
Kidney Int Rep
. 2024 Nov;
9(11):3083-3096.
PMID: 39534212
Hyperoxaluria is a condition in which there is a pathologic abundance of oxalate in the urine through either hepatic overproduction (primary hyperoxaluria [PH]) or excessive enteric absorption of dietary oxalate...
2.
Patel B, Patel K, Lee C, Moochhala S
Int J Mol Sci
. 2024 Sep;
25(18).
PMID: 39337561
Recent years have witnessed an uptick in research highlighting the gut microbiota's role as a primary determinant of athletes' health, which has piqued interest in the hypothesis that it correlates...
3.
Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Masoud S, et al.
Kidney Int Rep
. 2024 Jul;
9(7):2067-2083.
PMID: 39081723
Introduction: The National Registry of Rare Kidney Diseases (RaDaR) collects data from people living with rare kidney diseases across the UK, and is the world's largest, rare kidney disease registry....
4.
Wong K, Pitcher D, Braddon F, Downward L, Steenkamp R, Annear N, et al.
Lancet
. 2024 Mar;
403(10433):1279-1289.
PMID: 38492578
Background: Individuals with rare kidney diseases account for 5-10% of people with chronic kidney disease, but constitute more than 25% of patients receiving kidney replacement therapy. The National Registry of...
5.
DAmbrosio V, Moochhala S, Unwin R, Ferraro P
Expert Rev Clin Pharmacol
. 2022 May;
15(4):407-414.
PMID: 35612529
Introduction: Progress in the medical treatment and management of nephrolithiasis has been limited to date and continues to depend on urinary metabolic screening to assess excretion of the main stone...
6.
Hogh J, Ebrahim H, Moochhala S, Ramaswami U
BMJ Case Rep
. 2022 May;
15(5).
PMID: 35537774
Fabry disease is an X-linked lysosomal storage disorder caused by reduced activity or absence of the alpha-galactosidase A enzyme resulting in systemic accumulation of glycosphingolipids. End-stage renal disease (ESRD) is...
7.
Huang R, Lee C, Moochhala S
Front Microbiol
. 2021 Dec;
12:709562.
PMID: 34867837
The serological lateral flow immunoassay (LFIA) was used to detect circulating antibodies to skin bacteria. Next-generation sequencing analysis of the skin microbiome revealed a high relative abundance of but low...
8.
Bargagli M, Moochhala S, Robertson W, Gambaro G, Lombardi G, Unwin R, et al.
J Nephrol
. 2021 Jun;
35(3):851-857.
PMID: 34152561
Objective: Kidney stone disease seems to be associated with an increased risk of incident cardiovascular outcomes; the aim of this study is to identify differences in 24-h urine excretory profiles...
9.
Huang R, Herr D, Moochhala S
Microorganisms
. 2020 May;
8(5).
PMID: 32455676
Endogenous alcohol produced by the gut microbiome is transported via the bloodstream to the liver for detoxification. Gut dysbiosis can result in chronic excess alcohol production that contributes to the...
10.
Ferraro P, Arrabal-Polo M, Capasso G, Croppi E, Cupisti A, Ernandez T, et al.
Urolithiasis
. 2019 Mar;
47(3):219-224.
PMID: 30848320
Currently an evidence-based approach to nephrolithiasis is hampered by a lack of randomized controlled trials. Thus, there is a need for common platforms for data sharing and recruitment of patients...